These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 17692976)

  • 41. Dosimetric and toxicity comparison between prone and supine position IMRT for endometrial cancer.
    Beriwal S; Jain SK; Heron DE; de Andrade RS; Lin CJ; Kim H
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):485-9. PubMed ID: 17084548
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cluster model analysis of late rectal bleeding after IMRT of prostate cancer: a case-control study.
    Tucker SL; Zhang M; Dong L; Mohan R; Kuban D; Thames HD
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1255-64. PubMed ID: 16504763
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chronic genitourinary and gastrointestinal toxicity of prostate cancer patients undergoing pelvic radiotherapy with intensity-modulated versus 4-field technique.
    Su AW; Jani AB
    Am J Clin Oncol; 2007 Jun; 30(3):215-9. PubMed ID: 17551295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patient-reported toxicity correlated to dose-volume histograms of the rectum in radiotherapy of the prostate.
    Taussky D; Schneider U; Rousson V; Pescia R
    Am J Clin Oncol; 2003 Oct; 26(5):e144-9. PubMed ID: 14528089
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Principal component analysis-based pattern analysis of dose-volume histograms and influence on rectal toxicity.
    Söhn M; Alber M; Yan D
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):230-9. PubMed ID: 17707277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Searching for optimal dose-volume constraints to reduce rectal toxicity after hypofractionated radiotherapy for prostate cancer.
    Faria S; Joshua B; Patrocinio H; Dal Pra A; Cury F; Velly AM; Souhami L
    Clin Oncol (R Coll Radiol); 2010 Dec; 22(10):810-7. PubMed ID: 20980135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of dose and volume on rectal tolerance.
    Gambacorta MA; Manfrida S; D'Agostino G; Digesù C; D'Onofrio I; Rosato H; Valentini V
    Rays; 2005; 30(2):181-7. PubMed ID: 16294912
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy.
    Wong GW; Palazzi-Churas KL; Jarrard DF; Paolone DR; Graf AK; Hedican SP; Wegenke JD; Ritter MA
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):449-55. PubMed ID: 17869014
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Significant reduction of acute toxicity following pelvic irradiation with helical tomotherapy in patients with localized prostate cancer.
    Cozzarini C; Fiorino C; Di Muzio N; Alongi F; Broggi S; Cattaneo M; Montorsi F; Rigatti P; Calandrino R; Fazio F
    Radiother Oncol; 2007 Aug; 84(2):164-70. PubMed ID: 17706308
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of late gastrointestinal and genitourinary toxicity of prostate cancer patients undergoing intensity-modulated versus conventional radiotherapy using localized fields.
    Jani AB; Su A; Correa D; Gratzle J
    Prostate Cancer Prostatic Dis; 2007; 10(1):82-6. PubMed ID: 16983394
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Intensity modulated radiotherapy as adjuvant post-operative treatment for retroperitoneal sarcoma: acute toxicity].
    Paumier A; Bonvalot S; Beaudré A; Terrier P; Rimareix F; Domont J; Le Cesne A; Roberti E; Lefkopoulos D; Le Péchoux C
    Cancer Radiother; 2011 Aug; 15(5):413-20. PubMed ID: 21737334
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 3-D conformal radiotherapy of localized prostate cancer: a subgroup analysis of rectoscopic findings prior to radiotherapy and acute/late rectal side effects.
    Goldner G; Zimmermann F; Feldmann H; Glocker S; Wachter-Gerstner N; Geinitz H; Becker G; Pötzi R; Wambersie A; Bamberg M; Molls M; Wachter S; Pötter R
    Radiother Oncol; 2006 Jan; 78(1):36-40. PubMed ID: 16271410
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute and late toxicity in prostate cancer patients treated by dose escalated intensity modulated radiation therapy and organ tracking.
    Ghadjar P; Vock J; Vetterli D; Manser P; Bigler R; Tille J; Madlung A; Behrensmeier F; Mini R; Aebersold DM
    Radiat Oncol; 2008 Oct; 3():35. PubMed ID: 18937833
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical correlations between treatment with anticoagulants/antiaggregants and late rectal toxicity after radiotherapy for prostate cancer.
    Takeda K; Ogawa Y; Ariga H; Koto M; Sakayauchi T; Fujimoto K; Narazaki K; Mitsuya M; Takai Y; Yamada S
    Anticancer Res; 2009 May; 29(5):1831-4. PubMed ID: 19443412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. To bleed or not to bleed. A prediction based on individual gene profiling combined with dose-volume histogram shapes in prostate cancer patients undergoing three-dimensional conformal radiation therapy.
    Valdagni R; Rancati T; Ghilotti M; Cozzarini C; Vavassori V; Fellin G; Fiorino C; Girelli G; Barra S; Zaffaroni N; Pierotti MA; Gariboldi M
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1431-40. PubMed ID: 19211196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of a set of nomograms to predict acute lower gastrointestinal toxicity for prostate cancer 3D-CRT.
    Valdagni R; Rancati T; Fiorino C; Fellin G; Magli A; Baccolini M; Bianchi C; Cagna E; Greco C; Mauro FA; Monti AF; Munoz F; Stasi M; Franzone P; Vavassori V
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1065-73. PubMed ID: 18234449
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low rectal toxicity after dose escalated IMRT treatment of prostate cancer using an absorbable hydrogel for increasing and maintaining space between the rectum and prostate: results of a multi-institutional phase II trial.
    Uhl M; van Triest B; Eble MJ; Weber DC; Herfarth K; De Weese TL
    Radiother Oncol; 2013 Feb; 106(2):215-9. PubMed ID: 23333011
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amifostine as radioprotective agent for the rectal mucosa during irradiation of pelvic tumors. A phase II randomized study using various toxicity scales and rectosigmoidoscopy.
    Kouvaris J; Kouloulias V; Malas E; Antypas C; Kokakis J; Michopoulos S; Matsopoulos G; Vlahos L
    Strahlenther Onkol; 2003 Mar; 179(3):167-74. PubMed ID: 12627259
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low-grade toxicity after conformal radiation therapy for prostate cancer--impact of bladder volume.
    Pinkawa M; Fischedick K; Asadpour B; Gagel B; Piroth MD; Eble MJ
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):835-41. PubMed ID: 16289911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute toxicity of whole-pelvis IMRT in 87 patients with localized prostate cancer.
    Sanguineti G; Endres EJ; Parker BC; Bicquart C; Little M; Chen G; Berilgen J
    Acta Oncol; 2008; 47(2):301-10. PubMed ID: 18210303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.